C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes
After obtaining informed consent, serum samples were collected from septic (severe sepsis or septic shock) ventilated patients with ARDS (from 2009 - 2014), from patients with pneumonia who progressed to ARDS (from 2009 - 2014) and from ventilated ICU control patients during the same time period and...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 2017-01, Vol.195 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | American journal of respiratory and critical care medicine |
container_volume | 195 |
creator | Winston, B Donnelly, S Banoei, M Metwaly, S Mourad, A Vogel, H |
description | After obtaining informed consent, serum samples were collected from septic (severe sepsis or septic shock) ventilated patients with ARDS (from 2009 - 2014), from patients with pneumonia who progressed to ARDS (from 2009 - 2014) and from ventilated ICU control patients during the same time period and stored in CCEPTR, an ICU tissue bank. 96 sepsis-induced (indirect lung injury) ARDS patients and 56 pneumonia-induced (direct lung injury) ARDS were identified and compared. The PLS-DA data comparing these three groups reveals a model with an R2 = 0.66, Q2 = 0.44, p = 1.977 x 10-35. [...]NMR metabolomics data analysis reveals good ARDS endotype separation. |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1926718931</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1926718931</sourcerecordid><originalsourceid>FETCH-proquest_journals_19267189313</originalsourceid><addsrcrecordid>eNqNik8LgjAcQEcU9Pc7_KCzsKVmdlu6aqATckI3sVpllCtnh759HvoAnd6D9zpoQFzbtRzfw93WsWdbjuPv-2hozA1jMlsQPEDXoC0Qc5kE20SEO06BihBiJukqiXgANJJsRyVPRApcQJSJDYQ8ZTRlS8hMWV0gVk1x0Hf9KI8GpIZQnctKAa1PBlh10s3nqcwY9c7F3ajJjyM0XTMZbK1nrV9vZZr8pt911aac-LO5Rxa-Tez_ri8-QkKP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1926718931</pqid></control><display><type>article</type><title>C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Winston, B ; Donnelly, S ; Banoei, M ; Metwaly, S ; Mourad, A ; Vogel, H</creator><creatorcontrib>Winston, B ; Donnelly, S ; Banoei, M ; Metwaly, S ; Mourad, A ; Vogel, H</creatorcontrib><description>After obtaining informed consent, serum samples were collected from septic (severe sepsis or septic shock) ventilated patients with ARDS (from 2009 - 2014), from patients with pneumonia who progressed to ARDS (from 2009 - 2014) and from ventilated ICU control patients during the same time period and stored in CCEPTR, an ICU tissue bank. 96 sepsis-induced (indirect lung injury) ARDS patients and 56 pneumonia-induced (direct lung injury) ARDS were identified and compared. The PLS-DA data comparing these three groups reveals a model with an R2 = 0.66, Q2 = 0.44, p = 1.977 x 10-35. [...]NMR metabolomics data analysis reveals good ARDS endotype separation.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><language>eng</language><publisher>New York: American Thoracic Society</publisher><subject>Data analysis ; Discriminant analysis ; Intensive care ; Metabolism ; Nitric oxide ; NMR ; Nuclear magnetic resonance ; Pneumonia ; Sepsis</subject><ispartof>American journal of respiratory and critical care medicine, 2017-01, Vol.195</ispartof><rights>Copyright American Thoracic Society 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Winston, B</creatorcontrib><creatorcontrib>Donnelly, S</creatorcontrib><creatorcontrib>Banoei, M</creatorcontrib><creatorcontrib>Metwaly, S</creatorcontrib><creatorcontrib>Mourad, A</creatorcontrib><creatorcontrib>Vogel, H</creatorcontrib><title>C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes</title><title>American journal of respiratory and critical care medicine</title><description>After obtaining informed consent, serum samples were collected from septic (severe sepsis or septic shock) ventilated patients with ARDS (from 2009 - 2014), from patients with pneumonia who progressed to ARDS (from 2009 - 2014) and from ventilated ICU control patients during the same time period and stored in CCEPTR, an ICU tissue bank. 96 sepsis-induced (indirect lung injury) ARDS patients and 56 pneumonia-induced (direct lung injury) ARDS were identified and compared. The PLS-DA data comparing these three groups reveals a model with an R2 = 0.66, Q2 = 0.44, p = 1.977 x 10-35. [...]NMR metabolomics data analysis reveals good ARDS endotype separation.</description><subject>Data analysis</subject><subject>Discriminant analysis</subject><subject>Intensive care</subject><subject>Metabolism</subject><subject>Nitric oxide</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Pneumonia</subject><subject>Sepsis</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNik8LgjAcQEcU9Pc7_KCzsKVmdlu6aqATckI3sVpllCtnh759HvoAnd6D9zpoQFzbtRzfw93WsWdbjuPv-2hozA1jMlsQPEDXoC0Qc5kE20SEO06BihBiJukqiXgANJJsRyVPRApcQJSJDYQ8ZTRlS8hMWV0gVk1x0Hf9KI8GpIZQnctKAa1PBlh10s3nqcwY9c7F3ajJjyM0XTMZbK1nrV9vZZr8pt911aac-LO5Rxa-Tez_ri8-QkKP</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Winston, B</creator><creator>Donnelly, S</creator><creator>Banoei, M</creator><creator>Metwaly, S</creator><creator>Mourad, A</creator><creator>Vogel, H</creator><general>American Thoracic Society</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170101</creationdate><title>C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes</title><author>Winston, B ; Donnelly, S ; Banoei, M ; Metwaly, S ; Mourad, A ; Vogel, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19267189313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Data analysis</topic><topic>Discriminant analysis</topic><topic>Intensive care</topic><topic>Metabolism</topic><topic>Nitric oxide</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Pneumonia</topic><topic>Sepsis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winston, B</creatorcontrib><creatorcontrib>Donnelly, S</creatorcontrib><creatorcontrib>Banoei, M</creatorcontrib><creatorcontrib>Metwaly, S</creatorcontrib><creatorcontrib>Mourad, A</creatorcontrib><creatorcontrib>Vogel, H</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winston, B</au><au>Donnelly, S</au><au>Banoei, M</au><au>Metwaly, S</au><au>Mourad, A</au><au>Vogel, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>195</volume><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>After obtaining informed consent, serum samples were collected from septic (severe sepsis or septic shock) ventilated patients with ARDS (from 2009 - 2014), from patients with pneumonia who progressed to ARDS (from 2009 - 2014) and from ventilated ICU control patients during the same time period and stored in CCEPTR, an ICU tissue bank. 96 sepsis-induced (indirect lung injury) ARDS patients and 56 pneumonia-induced (direct lung injury) ARDS were identified and compared. The PLS-DA data comparing these three groups reveals a model with an R2 = 0.66, Q2 = 0.44, p = 1.977 x 10-35. [...]NMR metabolomics data analysis reveals good ARDS endotype separation.</abstract><cop>New York</cop><pub>American Thoracic Society</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 2017-01, Vol.195 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_journals_1926718931 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload; American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection |
subjects | Data analysis Discriminant analysis Intensive care Metabolism Nitric oxide NMR Nuclear magnetic resonance Pneumonia Sepsis |
title | C107 MITOCHONDRIA AND METABOLIC ALTERATIONS IN LUNG DISEASE: Using Metabolomics To Define Ards Endotypes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T06%3A16%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=C107%20MITOCHONDRIA%20AND%20METABOLIC%20ALTERATIONS%20IN%20LUNG%20DISEASE:%20Using%20Metabolomics%20To%20Define%20Ards%20Endotypes&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Winston,%20B&rft.date=2017-01-01&rft.volume=195&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/&rft_dat=%3Cproquest%3E1926718931%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1926718931&rft_id=info:pmid/&rfr_iscdi=true |